Epoch Investment Partners’s Halozyme HALO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$86M Sell
1,098,532
-39,845
-4% -$2.72M 0.49% 73
2026
Q1
$73.6M Buy
1,138,377
+605,018
+113% +$42.7M 0.45% 89
2025
Q4
$35.9M Sell
533,359
-63,247
-11% -$4.25M 0.2% 146
2025
Q3
$43.8M Sell
596,606
-35,275
-6% -$2.34M 0.24% 142
2025
Q2
$32.9M Sell
631,881
-195,366
-24% -$11.1M 0.17% 159
2025
Q1
$52.8M Buy
827,247
+48,936
+6% +$2.84M 0.27% 140
2024
Q4
$37.2M Sell
778,311
-74,956
-9% -$3.84M 0.18% 168
2024
Q3
$48.8M Sell
853,267
-582,775
-41% -$33.4M 0.22% 163
2024
Q2
$75.2M Buy
1,436,042
+2,430
+0.2% +$107K 0.34% 103
2024
Q1
$58.3M Buy
1,433,612
+270,579
+23% +$10.1M 0.26% 137
2023
Q4
$43M Buy
1,163,033
+831,199
+250% +$31.3M 0.2% 179
2023
Q3
$12.7M Sell
331,834
-100
-0% -$4.1K 0.08% 236
2023
Q2
$12M Hold
331,934
0.07% 256
2023
Q1
$12.7M Buy
331,934
+143,580
+76% +$6.73M 0.08% 243
2022
Q4
$10.7M Buy
+188,354
New +$9.64M 0.06% 266

Other funds holding HALO

Epoch Investment Partners's HALO Position: Q2 2026 in Review

Epoch Investment Partners reduced its Halozyme (HALO) stake by 3.5% in Q2 2026, selling an estimated $2.72M and leaving 1,098,532 shares worth $86M. The position accounts for 0.49% of the portfolio, ranked #73.

Epoch Investment Partners first reported a position in HALO in Q4 2022 and has held it in 15 quarters since. 668 funds tracked by Wall St. Rank hold HALO as of Q2 2026.

  • Epoch Investment Partners held 1,098,532 shares of Halozyme worth $86M as of Q2 2026.
  • Epoch Investment Partners sold 39,845 Halozyme shares in Q2 2026, an estimated $2.72M.
  • Halozyme made up 0.49% of Epoch Investment Partners's portfolio in Q2 2026, its #73 holding.
  • Epoch Investment Partners first reported a position in Halozyme in Q4 2022 and has held it in 15 quarters since.
  • 668 funds tracked by Wall St. Rank held Halozyme as of Q2 2026.

Based on Epoch Investment Partners's 13F filing for Q2 2026, filed 13 Aug 2026.